An Evening Visit to the Sakharovs

If someone had told me last December that I would meet Andrel Sakharov six months later in Moscow, I—a notorious optimist—would have considered that person a fool. But in June, after unsuccessfully trying to call Sakharov shortly after my arrival in Moscow en route to a conference in Novosibirsk, I asked a friend to drive me to 48B Chkalov Street at around 9 p.m. I rang at the shabby door, which was opened by Yelena Bonner, Sakharov’s wife. She is used to late visitors, to

Written byFrantisek Janouch
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

If someone had told me last December that I would meet Andrel Sakharov six months later in Moscow, I—a notorious optimist—would have considered that person a fool. But in June, after unsuccessfully trying to call Sakharov shortly after my arrival in Moscow en route to a conference in Novosibirsk, I asked a friend to drive me to 48B Chkalov Street at around 9 p.m.

I rang at the shabby door, which was opened by Yelena Bonner, Sakharov’s wife. She is used to late visitors, to unknown people from Russia and abroad who come to this door unannounced. We had not seen each other since 1977, though we often have spoken by phone.

“Wait, I know you! Who are you? Frantisek!”

Yelena Georgievna embraced me and led me to the sitting room.

“Andrei Dmitrievich is sleeping, but I will wake him immediately.”

In a few minutes he appeared, wearing old velveteen ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies